In colorectal cancer (CRC), CXCL13 was detected in both T cells and tumor cells, and CXCL13 deletion characterized with fewer infiltrating TFH and B cells was associated with a higher recurrence rate and poorer survival [50]. Here, CXCL13 is linked to colorectal cancer.